The role of topoisomerase I inhibitor in cisplatin-resistant ovarian cancer.

Human cell : official journal of Human Cell Research Society

Volumn 14, Issue 3, 2001, Pages 237-243

  Minagawa, Y ^a   Kigawa, J ^a   Itamochi, H ^a   Terakawa, N ^a  

^a TOTTORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; 7-ETHYL-10-HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; DNA TOPOISOMERASE; DRUG DERIVATIVE; ENZYME INHIBITOR; IRINOTECAN;

ANIMAL; CELL CULTURE; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG RESISTANCE; ENZYMOLOGY; FEMALE; HELA CELL; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; REVIEW;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CISPLATIN; DNA TOPOISOMERASES, TYPE I; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ENZYME INHIBITORS; FEMALE; HELA CELLS; HUMANS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0035465471     PISSN: 09147470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)